You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.7% | 2.2% |
| Div Cover | 9.5 | 2.9 |
| Op Mrgn | 26.3% | 22.8% |
| ROCE | 68.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | 14.8 | 15.7 |
| PEG | 1.2 | -3.9 |
| Price / Revenue | 3.0 | 2.9 |
| Price / Book value | 1.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 14.7% | -9.9% |
| PBT | 36.3% | n/a |
| EPS | 12.1% | -12.2% |
| DPS | -63.4% | -7.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | 48.34 | 15.18 | 3.52p | 12.2 | 2.6 | 5% | 1.10p | 2.6% |
| 2016-12-31 | 97.49 | 22.22 | 3.85p | 12.3 | 1.3 | 9% | 1.21p | 2.6% |
| 2017-12-31 | 101.64 | 28.29 | 5.33p | 12.6 | 0.3 | 38% | 1.33p | 2.0% |
| 2018-12-31 | 118.21 | 22.80 | 4.54p | 14.8 | -1.0 | -15% | 1.46p | 2.2% |
| 2019-12-31 | 135.64 | 31.08 | 5.09p | 16.5 | 1.4 | 12% | 0.54p | 0.6% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 139.67 | 31.89 | 4.89p | 15.7 | -4.0 | -4% | 1.66p | 2.2% |
| 2021-12-31 | 148.00 | 35.61 | 5.46p | 13.8 | 1.2 | 12% | 1.84p | 2.4% |
| Alliance Pharma lowers net debt after "strong" revenue growth in 2019 Sharecast News | 22 Jan |
|---|---|
| Alliance Pharma handing back 'Xonvea' rights to Duchesnay Sharecast News | 27 Nov |
| Alliance Pharma revenues increase as product portfolio grows Sharecast News | 17 Jul |
| Notification of Major Holdings | 02-Jun-20 15:34 |
|---|---|
| Total Voting Rights | 01-Jun-20 11:08 |
| Notification of Major Holdings | 29-May-20 17:22 |
| Result of AGM | 18-May-20 14:45 |
| AGM Statement | 18-May-20 07:03 |